HIV Testing in Pregnancy [11F

Abstract

INTRODUCTION: The American College of Obstetricians and Gynecologists (ACOG) Committee Opinion and the Centers for Disease Control (CDC) guidelines regarding HIV testing in pregnancy state that women should be screened for HIV infection as early as possible during each pregnancy and receive a second HIV test during the third trimester. The purpose of this study is to determine if HIV testing in pregnancy is conducted according to proposed guidelines. METHODS: A retrospective review will be performed on all pregnant women who received at least one prenatal care visit and delivered a live-born infant(s) at an urban university medical center in Southern Florida from January 1–December 31, 2014. CPT billing codes for HIV testing during the prenatal and labor and delivery period will be identified. A subsequent record review will be performed to verify if testing was performed according to guidelines and documented. RESULTS: Preliminary data show that of 3200 live-born deliveries in 2014, 2,137 (66.7%) had at least one prenatal visit during pregnancy, and 1221 (38%) had at least one HIV test billed (HIV test- CPT code) during the pregnancy. Final data will report the gestational age at the first prenatal visit, initial HIV screening, subsequent third trimester screening, and screening on admission to labor and delivery, if indicated. CONCLUSION: Preliminary data based upon CPT billing codes for HIV testing demonstrates screening during pregnancy at an urban university medical center is grossly underperformed according to ACOG and CDC guidelines. Clinicians' adherence to HIV screening guidelines during pregnancy is paramount to eliminating perinatal HIV transmission.